June 24, 2015 / 4:53 PM / 4 years ago

USADA investigating if Salazar violated rules: source

(Reuters) - American coach Alberto Salazar is being investigated by the U.S. Anti-Doping Agency (USADA) to determine if anti-doping rules may have been violated, a source told Reuters.

May 30, 2014; Eugene, OR, USA; Galen Rupp (USA) embraces coach Alberto Salazar after winning the 10,000m in an American record 26:44.39 in the 40th Prefontaine Classic at Hayward Field. Kirby Lee-USA TODAY Sports

The agency is seeking documents and interviewing witnesses, the person, who is familiar with the investigation, said.

The probe has been ongoing and began before the BBC television programme Panorama in association with American website ProPublica made a series of allegations, the source said.

The allegations included that Salazar had given Olympic 10,000 metres silver medallist Galen Rupp the banned anabolic steroid testosterone.

Rupp is the training partner of British double Olympic champion Mo Farah, who has not been accused of any wrongdoing.

Salazar issued a lengthy and detailed denial of the allegations on Wednesday.

USADA would not comment on whether an investigation was taking place.

“USADA takes all reports of doping seriously and we aggressively follow up on all information we receive in order to fulfil our oath to protect clean athletes and the integrity of competition,” it said in a statement.

The Cuban-born Salazar, who has worked as a consultant to British Athletics for two years, wrote in an open letter published on Wednesday: “I believe in a clean sport and hard work and so do my athletes.

“I will never permit doping. At no time do we use science in violation of the WADA Code. We strictly adhere to competition and anti-doping rules at all times.

“I have not and will not condone any athlete I train using a banned substance and would never encourage any athlete to use a banned substance.”

Briton Farah, 32, won the 5,000 and 10,000 metres double at the 2012 London Olympics. American Rupp, 29, took the silver medal in the 10,000.

Rupp, the American record holder at 10,000 metres and six-times national champion, plans to defend his title at the U.S. world championships trials in Eugene, Oregon, on Thursday.

He has denied ever doping.


British Athletics said the content of Salazar’s statement would be referred to their performance oversight group for consideration in their ongoing internal review into the relationship between Salazar and Farah.

In his point-by-point response Salazar criticised the BBC and ProPublica, however Stephen Engelberg, editor in chief of ProPublica said: “Mr. Salazar’s statement confirms some details of our story, and purports to contradict other things that were not actually in the story.

“We will soon be detailing this, but can say now that we see nothing in the statement that would merit a correction.”

Among the allegations levelled at Salazar was that he had coached Rupp and other athletes on ways to manipulate therapeutic use exemptions (TUEs), in which athletes can use otherwise banned medications or treatments for medical reasons.

Salazar defended Rupp and said he had been treated for many years for asthma and Hashimoto’s disease, a thyroid disorder, but under medical supervision.

“Galen takes asthma medication so he can breathe normally —not so he can run better,” he said.

Using statistics to back up his claims, he stated: “I do not push my athletes to take prescription medicine that is not needed as alleged in the BBC/ProPublica stories.

“Again, the BBC/ProPublica writers did not want the facts to get in the way of their stories...”

The IAAF said it “is very comfortable with the current policy on TUEs — but this does not mean that in future there may not be changes.”

Writing by Ken Ferris and Toby Davis, editing by Martyn Herman

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below